| 8th Apr 2024 7:00 am |
RNS |
AVA6000 Abstract Release by AACR |
| 28th Mar 2024 4:00 pm |
RNS |
Investor Webinar |
| 21st Mar 2024 7:00 am |
RNS |
Update on AVA6000 Phase 1a Clinical Trial Progress |
| 18th Mar 2024 1:26 pm |
RNS |
Result of General Meeting |
| 6th Mar 2024 7:00 am |
RNS |
Avacta Announces AVA6000 Poster at AACR |
| 5th Mar 2024 7:00 am |
RNS |
Result of REX Retail Offer |
| 29th Feb 2024 7:00 am |
RNS |
Result of Placing |
| 28th Feb 2024 4:42 pm |
RNS |
Proposed REX Retail Offer |
| 28th Feb 2024 4:41 pm |
RNS |
Proposed Fundraise to progress Therapeutics |
| 16th Feb 2024 7:00 am |
RNS |
Share Incentive Plan/Issue of Equity |
| 22nd Jan 2024 10:51 am |
RNS |
Issue of Equity and Total Voting Rights |
| 19th Jan 2024 7:00 am |
RNS |
Appointment of Christina Coughlin |
| 19th Dec 2023 7:00 am |
RNS |
Appointment of Chief Business Officer |
| 13th Dec 2023 7:00 am |
RNS |
ALS-6000-101 Phase 1a Study Data |
| 4th Dec 2023 7:00 am |
RNS |
Shareholder update to review AVA6000 Phase 1a data |
| 27th Oct 2023 7:00 am |
RNS |
Block Listing Six Monthly Return |
| 23rd Oct 2023 1:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 18th Oct 2023 1:00 pm |
RNS |
Block Listing Application to AIM |
| 5th Oct 2023 7:00 am |
RNS |
Avacta to present at AACR-NCI-EORTC conference |
| 28th Sep 2023 7:00 am |
RNS |
Interim Results for the Period Ending 30 June 2023 |
| 20th Sep 2023 2:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 20th Sep 2023 7:01 am |
RNS |
Peel Hunt Appointed as Joint Broker |
| 20th Sep 2023 7:00 am |
RNS |
Appointment Dr.Christina Coughlin as a consultant |
| 19th Sep 2023 7:00 am |
RNS |
Successful Completion of Sixth Dose Escalation |
| 6th Sep 2023 7:00 am |
RNS |
Notice of Results |
| 21st Jul 2023 3:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 28th Jun 2023 11:00 am |
RNS |
Result of Annual General Meeting |
| 28th Jun 2023 7:00 am |
RNS |
Annual General Meeting and Shareholder Event |
| 21st Jun 2023 7:00 am |
RNS |
Completion of Fifth Dose Escalation in AVA6000 |
| 19th Jun 2023 7:01 am |
RNS |
Director Appointment |
| 19th Jun 2023 7:00 am |
RNS |
Statement regarding market speculation |
| 8th Jun 2023 7:00 am |
RNS |
AGM and Shareholder Event Detailed Agenda |
| 5th Jun 2023 7:00 am |
RNS |
Second Milestone in AffyXell Joint Venture |
| 2nd Jun 2023 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 1st Jun 2023 7:00 am |
RNS |
Avacta acquires Coris Bioconcept |
| 27th Apr 2023 7:00 am |
RNS |
Block Listing Six Monthly Return |
| 27th Apr 2023 7:00 am |
RNS |
First Patient Dosed in the US in AVA6000 Phase 1 |
| 25th Apr 2023 7:00 am |
RNS |
Preliminary Results |
| 21st Apr 2023 2:49 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 17th Apr 2023 7:00 am |
RNS |
AVA3996 data poster presented at AACR |
